feed,title,long_url,short_url
Benzinga,Cellectar Bio Stock Drops After ASCO Presentation on White Blood Cell Cancer Therapy,https://benzinga.com/general/biotech/21/06/21433466/cellectar-bio-stock-drops-after-asco-presentation-on-white-blood-cell-cancer-therapy,https://j.mp/3uTKsAr
Benzinga,Novartis' Neuroendocrine Tumors Targeted Radiotherapy Takes Small Hit on Clinically Relevant Overall Survival,https://benzinga.com/general/biotech/21/06/21432970/novartis-neuroendocrine-tumors-targeted-radiotherapy-takes-small-hit-on-clinically-relevant-overa,https://j.mp/34VaJ6B
